Effects of HA‐966 on conflict, social interaction, and plus maze behaviors
- 1 January 1991
- journal article
- Published by Wiley in Drug Development Research
- Vol. 24 (3) , 201-205
- https://doi.org/10.1002/ddr.430240302
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the ratPublished by Elsevier ,2002
- NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizationsEuropean Journal of Pharmacology, 1991
- The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptorEuropean Journal of Pharmacology, 1990
- Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.Proceedings of the National Academy of Sciences, 1990
- Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus mazeEuropean Journal of Pharmacology, 1989
- Excitatory amino acids in the brain - focus on NMDA receptorsTrends in Neurosciences, 1987
- 2-amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepamLife Sciences, 1986
- A social interaction model of anxiety sensitive to acutely administered benzodiazepinesDrug Development Research, 1984